Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV

Jinyu Xu, Jiali Wang, Simfukwe Keith, Mingyang Zhang, Chunhui Yang, Qing Yuan, Yiqing Qiu, Xiaowu Hu, Xi Wu, Jinyu Xu, Jiali Wang, Simfukwe Keith, Mingyang Zhang, Chunhui Yang, Qing Yuan, Yiqing Qiu, Xiaowu Hu, Xi Wu

Abstract

Introduction: Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson's disease (PD). On time follow-up and timely programing of symptoms are important measures to maintain the effectiveness of DBS. Due to the highly contagious nature of 2019-nCoV, patients were quarantined. With the help of Internet technologies, we continued to provide motor and non-motor symptom assessment and remote programming services for postsurgical PD-DBS patients during this extraordinary period.

Methods: A retrospective analysis was performed on postsurgical PD-DBS patients who could not come to our hospital for programming due to the impact of the 2019-nCoV. The differences between the pre- and post-programming groups were analyzed. We designed a 5-level Likert rating scale to evaluate the effects and convenience of the remote programming and Internet self-evaluation procedures.

Results: Of the 36 patients engaged in the remote programming, 32 patients met the inclusion criteria. Four of the 32 patients set initiated stimulation parameters, and the other 28 patients had significant improvement in UPDRS-III. Nearly all the 28 patients were satisfied with the effect of the remote programming. Most of the patients were willing to use remote programming again.

Conclusion: Remote programming based on the online evaluation of patient's symptoms can help improve motor symptoms of postsurgical DBS patients with PD during the quarantine period caused by 2019-nCoV.

Keywords: 2019-nCoV; Deep brain stimulation (DBS); Parkinson’s disease (PD); Remote programming; Telemedicine.

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Remote programming technology and method. The procedure of remote programming of patients
Fig. 2
Fig. 2
The Initial Programming Process of This Study

References

    1. Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol. 2011;68:1550–1556. doi: 10.1001/archneurol.2011.182.
    1. Ramirez-Zamora A, Ostrem JL. Globus pallidus interna or subthalamic nucleus deep brain stimulation for parkinson disease: a review. JAMA Neurol. 2018;75:367–372. doi: 10.1001/jamaneurol.2017.4321.
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.
    1. Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No 1). Beijing: China National Health Commission. (2020)
    1. Zhang C, Zhang Y, Zhan S, Li D, Jin H, Denys D, Sun B. Telemedical deep brain stimulation: merits and limitations. Stereotact Funct Neurosurg. 2018;96:272–273. doi: 10.1159/000491603.
    1. Yang C, Qiu Y, Wu X, Wang J, Wu Y, Hu X (2019) Analysis of contact position for subthalamic nucleus deep brain stimulation-induced hyperhidrosis. Parkinson's disease 2019:8180123. 10.1155/2019/8180123
    1. Chinese expert committee on Deep Brain Stimulation for Parkinson's Disease, Chinese expert consensus on deep brain stimulation for patients with Parkinson's disease (2012), Chin J Neurosurg 28:855–857
    1. Horn A, Kuhn AA. Lead-DBS: a toolbox for deep brain stimulation electrode localizations and visualizations. Neuroimage. 2015;107:127–135. doi: 10.1016/j.neuroimage.2014.12.002.
    1. Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, Penny WD. Statistical parametric mapping: the analysis of functional brain images. New York: Academic Press; 2011.
    1. Johnson HHG, Williams K. BRAINSFit: mutual information rigid registrations of whole-brain 3D images, using the insight toolkit. Insight J. 2007;57:51.
    1. Pourfar MH, Mogilner AY, Farris S, Giroux M, Gillego M, Zhao Y, Blum D, Bokil H, Pierre MC. Model-based deep brain stimulation programming for Parkinson's disease: the GUIDE pilot study. Stereotact Funct Neurosurg. 2015;93:231–239. doi: 10.1159/000375172.
    1. Chen Y, Hao H, Chen H, Li L (2015) The study on a telemedicine interaction mode for Deep Brain Stimulation postoperative follow-up. Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference 2015:186-189
    1. Zhang C, Li D, Zeljic K, Tan H, Ning Y, Sun B. A remote and wireless deep brain stimulation programming system. Neuromodulation. 2016;19:437–439. doi: 10.1111/ner.12448.
    1. Baizabal-Carvallo JF, Jankovic J. Movement disorders induced by deep brain stimulation. Parkinsonism Relat Disord. 2016;25:1–9. doi: 10.1016/j.parkreldis.2016.01.014.
    1. Picillo M, Lozano AM, Kou N, Puppi Munhoz R, Fasano A. Programming deep brain stimulation for Parkinson's disease: the toronto western hospital algorithms. Brain Stimul. 2016;9:425–437. doi: 10.1016/j.brs.2016.02.004.
    1. Ramirez-Zamora A, Kahn M, Campbell J, DeLaCruz P, Pilitsis JG. Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson's disease. J Neurol. 2015;262:578–584. doi: 10.1007/s00415-014-7605-3.
    1. Weiss D, Walach M, Meisner C, Fritz M, Scholten M, Breit S, Plewnia C, Bender B, Gharabaghi A, Wachter T, Kruger R. Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial. Brain. 2013;136:2098–2108. doi: 10.1093/brain/awt122.
    1. Tykocki T, Nauman P, Koziara H, Mandat T. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease. Stereotact Funct Neurosurg. 2013;91:12–17. doi: 10.1159/000342161.
    1. Wei XF, Grill WM. Impedance characteristics of deep brain stimulation electrodes in vitro and in vivo. J Neural Eng. 2009;6:046008. doi: 10.1088/1741-2560/6/4/046008.
    1. Chinese expert committee on Deep Brain Stimulation programming (2016) Chinese expert consensus on deep brain stimulation programming for patients with Parkinson's disease. Chin J Neurosurg 32:1192–1198
    1. (2015) The Guiding Opinions of the State Council on Actively Promoting the “Internet Plus” Action (No.40 [2015], the State Council): promote the new model of online medical and health care.
    1. (2018) Opinions of the General Office of the State Council on Promoting the Development of “Internet Plus Medical Health” (No. 26 [2018], the General Office of the State Council).
    1. (2016) The Outline of the Plan for “Healthy China 2030”: Developing Internet-based health care services.
    1. Antonini A, Gentile G, Giglio M, Marcante A, Gage H, Touray MML, Fotiadis DI, Gatsios D, Konitsiotis S, Timotijevic L, Egan B, Hodgkins C, Biundo R, Pellicano C, consortium PDM Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial. Trials. 2018;19:492. doi: 10.1186/s13063-018-2767-4.
    1. Terroba-Chambi C, Bruno V, Medina-Escobar A, Nanni F, Cerquetti D, Rossi M, Merello M. Open-access electronic diary for motor fluctuation and dyskinesia evaluation in Parkinson disease: comparison with paper diary. Clin Neuropharmacol. 2018;41:20–22. doi: 10.1097/WNF.0000000000000264.
    1. Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain. 2010;133:2664–2676. doi: 10.1093/brain/awq221.
    1. Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, Broussolle E, Thobois S. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol. 2009;256:225–233. doi: 10.1007/s00415-009-0076-2.
    1. Jiang LL, Liu JL, Fu XL, Xian WB, Gu J, Liu YM, Ye J, Chen J, Qian H, Xu SH, Pei Z, Chen L. Long-term efficacy of subthalamic nucleus deep brain stimulation in Parkinson's disease: a 5-year follow-up study in China. Chin Med J (Engl) 2015;128:2433–2438. doi: 10.4103/0366-6999.164925.
    1. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349:1925–1934. doi: 10.1056/NEJMoa035275.
    1. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010;25:578–586. doi: 10.1002/mds.22735.
    1. Rizzone MG, Fasano A, Daniele A, Zibetti M, Merola A, Rizzi L, Piano C, Piccininni C, Romito LM, Lopiano L, Albanese A. Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? Parkinsonism Relat Disord. 2014;20:376–381. doi: 10.1016/j.parkreldis.2014.01.012.
    1. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord. 2009;24:557–563. doi: 10.1002/mds.22390.
    1. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord. 2008;14:114–119. doi: 10.1016/j.parkreldis.2007.06.012.
    1. Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, Artusi CA, Arduino N, Marchisio A, Lanotte M, Rizzone M, Lopiano L. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord. 2011;26:2327–2334. doi: 10.1002/mds.23903.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere